Skip to main content
Premium Trial:

Request an Annual Quote

GeneWiz Taps Edico's Hardware to Support NGS Services

NEW YORK (GenomeWeb) – Genomics services provider GeneWiz said today that it will implement several of Edico Genome's Dragen bio-IT processors to improve its ability to analyze next-generation sequencing data for customers of its analysis services.

Edico's Dragen uses field-programmable gate arrays to provide hardware-accelerated implementations of bioinformatics algorithms for tasks such as BCL conversion, compression, mapping, alignment, sorting, duplicate marking, and haplotype variant calling. The platform includes pipelines for whole-genome and exome, transcriptome, joint genotyping, and methylation analysis. Users can also develop and implement custom algorithms on the platform as well as refine and improve existing pipelines.

GeneWiz offers NGS, Sanger DNA sequencing, gene synthesis, and molecular biology services on various sequencing platforms including the Illumina HiSeq X Ten, Pacific Biosciences Sequel system, and 10x Genomics Chromium platform. By adding the Dragen processors to its business, GeneWiz expects to be able to reduce turnaround times for large next-generation sequencing datasets by days without sacrificing the quality of the data or its integrity. 

"By adding Dragen to our workflow, we're able to process the sizable amounts of data coming off these sequencers many times faster to accelerate our customers' research projects and discoveries," GeneWiz Chief Informatics Office Ethan Ge said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.